1965MO Phase II Study of Futibatinib Plus Pembrolizumab in Patients (pts) with Advanced/metastatic Urothelial Carcinoma (muc): Final Analysis of Efficacy and Safety
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined